Following today’s announcement by UK Anti-Doping regarding the case of Richard Freeman, British Cycling Chair Frank Slevin has issued the following statement.

“We note today's verdict from the National Anti-Doping Panel and thank them for the time and consideration put into reaching their decision.

“Throughout this case we have reiterated our belief that it is in public interest and best interests of our sport that all matters are heard and thoroughly examined by the relevant authorities. As such, we have made every effort to support both UK Anti-Doping and the General Medical Council in their respective investigations, and will continue to do so on any matters arising in the future.

“We have stated previously that Richard Freeman’s conduct during his employment by British Cycling bore no resemblance to the high ethical and professional standards which we, our members and our partners rightly expect. 

“We also acknowledge that many will be understandably frustrated, as we are ourselves, that some matters arising from this case and others remain uncertain. We once again want to take this opportunity to urge individuals with relevant information to share that with UK Anti-Doping.

“In the years since Freeman was suspended from his employment by British Cycling, we have made great progress in strengthening our provision of medical services to riders competing for the Great Britain Cycling Team. Being granted Care Quality Commission status in October 2020 – making us one of the first professional sport medical facilities to achieve the status – is testament to the progress we have made.

“Ensuring that British Cycling remains at the forefront of our sector in this area will continue to be a key priority for us, and under the leadership of our Chief Medical Officer, Dr Nigel Jones, I am incredibly proud of the support we are providing both to our funded riders and wider sport.”